Drug Profile
Research programme: HIV vaccine - GlycoMimetics/Glycosensors/International AIDS Vaccine Initiative
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GlycoMimetics; International AIDS Vaccine Initiative
- Class Viral vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in USA
- 11 May 2012 Preclinical trials in HIV infections in USA (unspecified route)